-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Helen Y. Lee, PharmD, MBA

Articles by Helen Y. Lee, PharmD, MBA

Concern Still Warranted: Medication Burden and Persistence with Lipid-Lowering Drugs

ByJennifer M. Polinski, MPS, MS,Joshua J. Gagne, PharmD, MS. Reply by Teisha A. Robertson, PharmD, MBA,Catherine E. Cooke, PharmD, BCPS,Jingshu J. Wang, PhD, MPH,Fadia T. Shaya, PhD, MPS,Helen Y. Lee, PharmD, MBA

December 31st 2008

Effect of Medication Burden on Persistent Use of Lipid-Lowering Drugs Among Patients With Hypertension

ByTeisha A. Robertson, PharmD, MBA,Catherine E. Cooke, PharmD, BCPS,Jingshu Wang, PhD,Fadia T. Shaya, PhD, MPH,Helen Y. Lee, PharmD, MBA

November 14th 2008

This study assesses the effect of medication burden on persistent use of newly added lipid-lowering drugs among patients with hypertension.

Latest Updated Articles

Concern Still Warranted: Medication Burden and Persistence with Lipid-Lowering Drugs
December 31st 2008
Effect of Medication Burden on Persistent Use of Lipid-Lowering Drugs Among Patients With Hypertension
November 14th 2008

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC